Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES TO STOCKHOLDERS EQUITY (DEFICIT)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF CHANGES TO STOCKHOLDERS EQUITY (DEFICIT) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2012 $ 700 $ 143,447 $ (144,216) $ (69)
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Shares issued for PhytoSPHERE Agreement, shares 4,741,667      
Shares issued for PhytoSPHERE Agreement, value 474 27,549,528   27,550,002
To record the value of the beneficial conversion feature of new debt   637,400   637,400
Net loss     (28,407,209) (28,407,209)
Ending balance, value at Sep. 30, 2013 $ 1,174 $ 28,330,375 $ (28,551,425) $ (219,876)
Ending balance, shares at Sep. 30, 2013 11,741,667